Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.550
-0.130 (-3.53%)
At close: Mar 6, 2026, 4:00 PM EST
3.550
0.00 (0.00%)
After-hours: Mar 6, 2026, 4:10 PM EST

MRVI Revenue

In the year 2025, Maravai LifeSciences Holdings had annual revenue of $185.74M, down -28.34%. Maravai LifeSciences Holdings had revenue of $49.87M in the quarter ending December 31, 2025, a decrease of -11.83%.

Revenue (ttm)
$185.74M
Revenue Growth
-28.34%
P/S Ratio
4.94
Revenue / Employee
$337,715
Employees
550
Market Cap
912.59M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025185.74M-73.44M-28.34%
Dec 31, 2024259.19M-29.76M-10.30%
Dec 31, 2023288.95M-594.06M-67.28%
Dec 31, 2022883.00M83.76M10.48%
Dec 31, 2021799.24M515.14M181.33%
Dec 31, 2020284.10M140.96M98.48%
Dec 31, 2019143.14M19.31M15.59%
Dec 31, 2018123.83M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Fortrea Holdings2.72B
MannKind348.97M
Geron183.88M
UroGen Pharma109.79M
Arbutus Biopharma14.61M
Compass Therapeutics850.00K
Revenue Rankings